10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Short Interest

View and export this data going back to 2022. Start your Free Trial

What is 10X Capital Venture Acquisition III Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of 10X Capital Venture Acquisition III's Short Interest

For the Shell Companies subindustry, 10X Capital Venture Acquisition III's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

10X Capital Venture Acquisition III's Short Interest Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, 10X Capital Venture Acquisition III's Short Interest distribution charts can be found below:

* The bar in red indicates where 10X Capital Venture Acquisition III's Short Interest falls into.

10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » 10X Capital Venture Acquisition Corp III (AMEX:VCXBU) » Definitions » Short Interest

Comparable Companies

BCSA LCW GAQ FLME CHEA EVE HCMA SUAC ALCY HHLA PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA

Traded in Other Exchanges

VCXB:USA

Address

1 World Trade Center, 85th Floor, New York, NY, USA, 10007

Website

https://www.10xspac.com

10X Capital Venture Acquisition Corp III is a blank check company.

10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Headlines

From GuruFocus

Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III

By GlobeNewswire • 08-10-2023